Oaktree Acquisition Corp. III Life Sciences (OACC) Change in Cash (2025 - 2026)
Oaktree Acquisition Corp. III Life Sciences filings provide 2 years of Change in Cash readings, the most recent being -$158035.0 for Q1 2026.
- Quarterly Change in Cash fell 109.15% to -$158035.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was -$4553.0 through Mar 2026, changed N/A year-over-year, with the annual reading at $77921.0 for FY2025, 94.26% down from the prior year.
- Change in Cash hit -$158035.0 in Q1 2026 for Oaktree Acquisition Corp. III Life Sciences, down from $106124.0 in the prior quarter.
- Across five years, Change in Cash topped out at $106124.0 in Q4 2025 and bottomed at -$158035.0 in Q1 2026.